2003
U.S. Study Continues Guidant''s Leadership in Clinical Science St. Paul, Minn. and Indianapolis, Ind. - Guidant Corporation (NYSE: GDT), a world leader in the treatment of cardiac and vascular...
MULTI-LINK PENTA Stent System Brings Guidant''s Outstanding Stent Design Technology to Japanese Physicians and Patients Indianapolis, Ind. and Tokyo - Guidant Corporation (NYSE: GDT), a world...
FX miniRAIL Coronary Device Aims to Expand Physicians'' Options In the Treatment of De Novo Lesions and In-Stent Restenosis Indianapolis, Ind. - Guidant Corporation (NYSE: GDT), a world leader in...
Indianapolis, Ind. - Guidant Corporation (NYSE: GDT), a world leader in the treatment of cardiac and vascular disease, today announced that Dana G. Mead, Jr., currently vice president, Corporate...
Presentation Accessible Via Webcast Indianapolis, Ind. - Guidant Corporation (NYSE and PCX: GDT), a world leader in the treatment of cardiac and vascular disease, today announced that it will...
Company Sets Date for Annual Meeting of Shareholders Indianapolis, Ind. - Guidant Corporation (NYSE and PCX: GDT), a world leader in the treatment of cardiac and vascular disease, today announced...
INSIGNIA Entra is Small, Smart and Long-Lasting Indianapolis, Ind. and St. Paul, Minn. - Guidant Corporation (NYSE and PCX: GDT), a world leader in the treatment of cardiac and vascular disease,...
Live Webcast Available Indianapolis, Ind. - Guidant Corporation (NYSE and PCX: GDT), a world leader in the treatment of cardiac and vascular disease, will host a conference call to provide an...
Medicare Coverage Advisory Committee Recommends Expanding Coverage to Include MADIT II Patients Indianapolis, Ind. and St. Paul, Minn. - Guidant Corporation (NYSE and PCX: GDT), a world leader in...
Background Materials Available for Review Online Indianapolis, Ind. - Guidant today announced that background materials from Guidant have been provided to the Centers for Medicare and Medicaid...